The implementation of the new pharmacopoeia will have a tremor in the pharmaceutical industry in January
Release time: 2010-11-12 & nbsp & nbsp & nbsp Source:
The new version of the Pharmacopoeia uses new quality requirements，higher control standards，Further improve the quality of Chinese medicines，At the same time, Chinese drug standards have rushed to overtake Europe and the United States。
One of the highlights of the new version of Pharmacopoeia is the increase in the number of loaded varieties，More widely adopted advanced technology and analysis methods at home and abroad。The new version of Pharmacopoeia forms Chinese medicinal materials、Traditional Chinese Medicine Drinking Film、Chinese Medicine、Chemicals、Medicinal Accessories、Biological products and other categories of category categories。solved the long -term Chinese medicinal materials、Traditional Chinese Medicine Drinks and Common Medical Accessories Lack of Standards and Insufficient Issues。This means，China's Chinese medicine industry has received full attention，More standardization and standardization。
An Analysis of the Chairman of Sichuan Shu Traditional Chinese Medicine Group An Analysis: With the gradual approach of the Chinese Pharmacopoeia standard and the level of foreign quality，The intention of taking the internationalization line of the Chinese medicine industry is very obvious。Before that，All nationwide，From planting to production，Construction from the secondary development to the development of new drug development，It will become the general trend。
Standards to increase the standard New development trend presentation
During the revision of the new version of the Pharmacopoeia，Including a number of foreign biological products enterprises and domestic medical leading enterprises participating in it。These companies mostly have high -tech advantages，Someone is worried，New technical barriers may be formed here。
But，An Haoyi doesn’t think so。He thinks，The industrial concentrated development trend after the new version of the pharmacopoeia，It will become a feast of a few companies。and the new technical barriers are also considered a necessary means to improve the level of industrial level。Only this，The level of China's pharmaceutical industry can gradually shorten the possibility of gradually shortening the international distance。This process，Chinese medicine is the stake sports betting appstake online sports bettingtop priority，It is also the "unique cheats" that China participated in international competition。
The new version of the Pharmacopoeia fully emphasizes the special status of Chinese medicine，Perseverance on the basis of comprehensive inheritance of fine traditions，The characteristics of Chinese medicine embodying Chinese medicine，Adjust the compilation method of proprietary Chinese medicine prescription，Make it more in line with the clinical practice of "drinking tablets for medicines" in Chinese medicine。At the same time，significantly increased the dedicated properties of the characteristics of traditional Chinese medicine。
As a 30 -year -old pharmaceutical man，An Haoyi can grasp the deep meaning behind these new signs in a deeper level: a new development trend will present，and develop into the mainstream of the Chinese medicine industry in the short term。and those with huge technical advantages、Great Innovation Achievement、Good forward -looking and strong funds and investment consciousness companies，Will enjoy this future mainstream feast。
From two aspects,，One aspect，Standards drive the improvement of demand。More systematic and strict drink control standards，Make the source quality control of the medicinal material，The fundamental control of the quality control of Chinese medicine。From the perspective of changes in the medicinal market in recent years，Yizhou、An Guo and other four medicinal materials market with the distribution center of the distribution center of Anguo shows that there are uneven quality、Supply hyaccharge、Characteristics such as advantages and disadvantages，The difficulty of quality control of the medicinal material increases significantly。Because the "authenticity" of traditional Chinese medicine emphasizes the "authenticity" of traditional Chinese medicine has limited the improvement of the quality of Chinese medicine。So，Industrialization of traditional Chinese medicine planting、intensive development becomes a general trend。On the other hand，Innovation，is the only way out of national medicine to go to the world。
Layout of the new industrial chain
In view of the in -depth prediction of the development of the Chinese medicine industry，An Haoyi led Shu Chinese Medicine to based on the new version of "Chinese Pharmacopoeia" and the new version of GMP that will be promulgated soon，Established a higher standard of industrialization of traditional Chinese medicine，Start the layout of the development of the drug industry chain。
Recent，The project department of Shuzhong Pharmaceutical Group authorized the Group's project department submitted the "Salva Medical Materials Standardized Planting and Deep Processing Projects" to the relevant units。The main content of the project includes the following aspects:
Standardized Chinese medicine planting Shu Traditional Chinese Medicine Industry to determine and evaluate the content of the main component of the fingerprint diagram of Danshen in different produces。From the measurement results，Shiquan Township, Zhongjiang Province, Sichuan Province, and Salvatophenol in Songlin Town, Guanghan Province, high content B，Other stake sports betting appstake online sports bettingstake sports betting appactive ingredients such as Tanzannone IIA are relatively high，belonging to authentic high -quality medicinal materials。After field inspection，Its natural and geographical environment can fully meet the requirements of establishing GAP specified Sands Sloteur medicinal materials。So，Shuzhong intends to divide the planting base into two phases，The first phase is intended to establish 2,000 acres of Salviat Pinerium medicinal materials in Songlin Town, Guanghan; the second phase is planned to establish 3,000 acres of Salviat Sophora -in Planting Base in Shiquan Town, Zhongjiang。
The new version of the "Pharmacopoeia" in the deep processing of Chinese medicine has about 70 % of the drug standards to be improved and improved，At the same time, it also puts forward higher requirements for the safety and efficiency of drugs。Shu Chinese Medicine Industry before July 2010，The revision of the internal control standard of the enterprise has been completed according to the pharmacopoeia。The current enterprise internal control standards in Shuzhong，Not only highlights the quality requirements of the new version of the pharmacopoeia，More typical features:
high，higher than national standards to invest in the effective ingredients of drugs，Make sure the drugs are high and efficient;
Essence，Fine control of production of various links，Several control of various indicators of drugs;
Yan，Strict standard execution management system of internal control standards，Training is in place，Responsibility is implemented to people，Make the standard smooth、Implementation in place;
Fine，Shuzhong's internal control standards attach importance to detail management，All small links produced，All in control;
New，Innovation equipment，Innovation Technology，Not only the introduction of high -precision production equipment at home and abroad，The first in China、The most refined equipment，To adapt to the existing production scale。Not only strictly implement the new version of Pharmacopoeia standard，At the same time, the first Chinese medicine green production method，Pay attention to the efficiency and safety of drugs，Use a new scientific production concept to inherit the essence of traditional Chinese medicine。
In the "Salva Medicine Materials Standardized Planting and Deep Processing Projects" submitted this time，The content of the in -depth processing of traditional Chinese medicine follows the above internal control standards。Vigorously develop high -purity Danshen extract，Extract the separation of the effective ingredients of Salva、Purification and refining ability，Can further increase the added value of Salviac products。
Development of varieties development in Shu's existing Dan Dan ginseng tablets containing Danshen medicinal materials、Tongli Granules、The annual sales of refined crown heart particles exceeded 10 million yuan。Through in -depth development of the above varieties，It will greatly increase the technology content of Danshen products，and improve product quality standards，Add new quality control indicators，The effectiveness of the product、Re -evaluation of safety，Stake Sports BettingStake Sports BettingMake sure the safety of people's medicine、Effective，It is expected to add 200 million yuan in sales revenue。At the same time，Develop a new Danshen Preparation，Rich existing product structure。
From 2005 to the present，Shuzhong has completed the in -depth development of multiple products，and cooperate with many research institutes such as the Institute，Advantages of the combination of industry -university -research。Current，The system quality research of multiple Chinese medicine varieties such as compound salvia has been completed，Its research results were highly affirmed by the Chinese Medicine Preparation Committee of the Pharmacopoeia Committee，It plays an important role in improving the quality standard of compound Danshen tablets in my country。
Industrial cooperation Extend the tentacles of the industrial chain
Shu Traditional Chinese Medicine since 2009，Continuously strengthen technological innovation and technological upgrade，In 2009, sales revenue achieved 1.8 billion yuan，increased by about 50%year -on -year，Among them, new products account for more than 20%of total sales revenue。Current，Company 8 in the research new drug project，Among them, 5 new medicines 3.1 new medicines，2 new medicines in Chinese medicine 2，New drug certificate transfer varieties 1，It is expected to be the end of 2010，The new drug project will reach 15。While strengthening the creation of new drugs，The company also plans to introduce more than 10 Chinese medicine varieties。To achieve the rapid industrialization of new drugs，The company is now building a supporting new dosage form、The design and transformation of the new workshop and other production capacity。All projects are expected to invest 2 billion yuan，Among them, the research of new drugs invests 75 million yuan，The supporting fixed assets with it invested 125 million yuan。The project is expected to add 1.5 billion yuan after the project is completed，New profit of 400 million yuan。
Recent，Sichuan Shu Traditional Chinese Medicine Group reached a consensus with the local government，The in -depth development of the Codonopotic Oral solution and the innovation work of the 潞 潞 潞 潞。According to the relevant person in charge，Shu Traditional Chinese Medicine will first invest in expanding the production scale of Codonopsis Oral solution、Deep development and create the latest single product marketing strategy。Later, we will invest in huge sums of money to develop new products，Following the oral solution of Codonopsis，Development more efficacy、Safety new type of 潞 潞。To ensure the original pharmaceutical material and quantity，Protective Land Medical Materials，Or it will establish a local ginseng GAP planting base in the local area，Planting and processing of the local party ginseng to standardization、Industrialization upgrade，Further improve the source quality of the party ginseng。
September 2010，At the 2010 International (Bozhou) Traditional Chinese Medicine Expo and the 26th National (Bozhou) Traditional Chinese Medicine Fair，Sichuan Shu Traditional Chinese Medicine Group established stake online sports bettingstake sports betting appa long -term Chinese medicine industry development cooperation project with the Yinzhou Municipal Government。Chairman of Shu Traditional Chinese Medicine Group An Haoyi was hired as a consultant for the development of Chinese medicine industry in Luzhou，Consultation certificate issued by Luzhou City Chang Niu Tao。
is the largest traditional Chinese pharmaceutical material distribution center，The first of the "four major cities" in China，Breeding more than 400 kinds of medicines with unique natural geographical conditions，It has formed the planting of Chinese medicinal materials、Processing to Chinese medicinal materials logistics trade，To the production of Chinese medicines、The more complete industrial chain developed。Relying on many favorable conditions in the local area，Sichuan Shu Traditional Chinese Medicine Group will establish a large -scale Chinese medicine purchasing and selling base，At present, large -scale medicinal storage warehouses have been completed，It is expected to be put into use next year。
In addition，Shuzhong will continue to follow the "industry -academia" combined road with colleges such as Sichuan University of Traditional Chinese Medicine。One aspect，Provide a practical venue for the upcoming high -quality students who are about to graduate，Integrate the knowledge learned，Really connecting theoretical connection; on the other hand，In the process of establishing a talent reserve in Shu，Adding more high education、Researchers with high skills，For Shuzhong to further expand the energy of new drug research and development scale reserve energy。
